Hera Fertility has unveiled SmartScore, a new AI-powered tool that simplifies fertility assessment for men by converting standard semen analysis results into a clear, actionable fertility probability score. The new technology aims to demystify male reproductive health and provide personalized guidance on the journey to fatherhood.
SmartScore tackles one of the most persistent challenges in fertility care: Translating complex medical data into understandable information that empowers patients. The tool analyzes key fertility markers—including sperm count, motility, and morphology—and generates a straightforward score on a scale of 1-100, with higher numbers indicating greater pregnancy probability.
“At Hera, our mission is to make fertility care more accessible and less intimidating, especially for men who have historically been overlooked in this space,” explained Thiv Paramsothy, CEO of Hera Fertility. “SmartScore is a game-changer because it gives men the clarity and confidence they need to take proactive steps towards building their families.”
What sets SmartScore apart from conventional semen analysis is its comprehensive approach to reproductive health. Rather than simply providing a fertility score, the platform delivers customized recommendations to help optimize fertility potential, including lifestyle modifications, nutritional advice, and specialist referrals when necessary.
This holistic methodology reflects Hera Fertility’s commitment to supporting individuals throughout their entire fertility journey, not just during the diagnostic phase. By offering actionable next steps, SmartScore transforms fertility assessment from a potentially anxiety-inducing experience into an empowering one.
The introduction of SmartScore comes at a notable time in reproductive health. Research indicates increasing rates of male infertility in recent years, with studies suggesting that sperm counts have declined over the past few decades.
“Fertility can be a complex and daunting topic, but SmartScore makes it easier for men to understand their reproductive health and take meaningful action,” said Dr. Andrew Sun, Medical Advisor at Hera Fertility. “By democratizing access to this critical information, we’re helping to break down the stigma around male infertility and empower individuals to take control of their fertility.”
SmartScore represents the growing connection between artificial intelligence and reproductive medicine. By using advanced algorithms to analyze fertility data, Hera has created a tool that enhances patient understanding and potentially improves outcomes by encouraging earlier intervention and lifestyle modifications.
The technology aligns with healthcare trends toward patient empowerment, personalized medicine, and the use of digital tools to expand access to specialized care. For men who might otherwise avoid seeking fertility assessment due to stigma, inconvenience, or uncertainty, SmartScore offers a more approachable entry point into reproductive healthcare.
With the launch of SmartScore, Hera Fertility continues to establish itself in the field of comprehensive fertility solutions. The company offers a range of services beyond SmartScore, including diagnostic testing and fertility treatments, all guided by a commitment to evidence-based, personalized care.
As awareness of male fertility issues grows and more couples seek support on their path to parenthood, tools like SmartScore will play an increasingly important role in reproductive healthcare. By simplifying complex medical information, reducing stigma, and providing actionable guidance, Hera Fertility is helping transform how individuals and couples approach family planning.